Folic acid/lactobacillus casei Interactions
There are 374 drugs known to interact with folic acid/lactobacillus casei, along with 2 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 3 are major, 370 are moderate, and 1 is minor.
- View all 374 medications that may interact with folic acid/lactobacillus casei
- View folic acid/lactobacillus casei alcohol/food interactions (1)
- View folic acid/lactobacillus casei disease interactions (2)
Most frequently checked interactions
View interaction reports for folic acid / lactobacillus casei and the medicines listed below.
- 5-HTP (5-hydroxytryptophan)
- Adderall (amphetamine / dextroamphetamine)
- Advair Diskus (fluticasone / salmeterol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aldactone (spironolactone)
- Aleve (naproxen)
- Allegra (fexofenadine)
- Alpha-Lipoic-Acid-300 (alpha-lipoic acid)
- Aminosyn II 3.5%-Dextrose 25%,Electrolytes,Ca (parenteral nutrition solution w/electrolytes)
- Apriso (mesalamine)
- Benadryl (diphenhydramine)
- Calcium 600 D (calcium / vitamin d)
- CoQ10 (ubiquinone)
- EPA Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Flonase (fluticasone nasal)
- Methotrexate LPF Sodium (methotrexate)
- Nasonex (mometasone nasal)
- Nature-Throid (thyroid desiccated)
- Osteo Bi-Flex Triple Strength (chondroitin / glucosamine)
- Plaquenil (hydroxychloroquine)
- Singulair (montelukast)
- Synthroid (levothyroxine)
- Vitamin B Complex 100 (multivitamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin B6 (pyridoxine)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xeljanz (tofacitinib)
- Zinc (zinc sulfate)
Folic acid/lactobacillus casei alcohol/food interactions
There is 1 alcohol/food interaction with folic acid / lactobacillus casei.
Folic acid/lactobacillus casei disease interactions
There are 2 disease interactions with folic acid / lactobacillus casei which include:
Report options
QR code containing a link to this page
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
